As Parkinson’s disease progresses, issues with timing and managing medications can become a challenge as more pills are added and fluctuations in on/off increase. DUOPA (carbidopa and levodopa) enteral suspension is a prescription medicine used for treatment of advanced Parkinson’s disease. DUOPA contains two medicines: carbidopa and levodopa.
In this presentation, Michael Vitti, Account Executive with Abbvie, will talk about PD with a focus on the changes that may occur in the gut as the disease progresses. He will describe what Duopa therapy is, how it works, who is a good candidate, information on the safety of this treatment, and what kind of resources Abbvie offers to make this a successful decision for you. Michael will also address the question of insurance coverage and discuss how Duopa therapy can be incorporated it into your life.
Maximize your learning and opportunity to have your questions answered by joining us live in person! Virtual registration is also an option. Please choose if you will be in-person or online when registering.
Who should attend?
PwP and family carepartners who want to stay current on options
PwP and family carepartners who have been recommended for the procedure
PwP and family carepartners who are noticing changes in symptom control
PRO does not endorse or recommend specific therapies and encourages you to work closely with your physician for the approach that is right for you.
This is an independent event with content provided by Abbvie Pharmaceuticals, and is not an endorsement or recommendation by PRO of a specific therapy or treatment modality. Abbvie Pharmaceuticals is a proud partner of Parkinson’s Resources of Oregon.